Oligohydramnios and Intrauterine Premature Closure of Ductus Arteriosus Associated with the Use of NSAIDs During Pregnancy – An Overview of Clinical Evidence

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
Naina Mohamed Pakkir Maideen, Sultan Al Rashid, M. Gobinath, Mohamed Harshath Jahir Hussain
{"title":"Oligohydramnios and Intrauterine Premature Closure of Ductus Arteriosus Associated with the Use of NSAIDs During Pregnancy – An Overview of Clinical Evidence","authors":"Naina Mohamed Pakkir Maideen, Sultan Al Rashid, M. Gobinath, Mohamed Harshath Jahir Hussain","doi":"10.2174/0115748855308697240409035903","DOIUrl":null,"url":null,"abstract":"\n\nPregnant women may experience low back pain and other pain symptoms,\nfever, and inflammatory conditions that may harm the fetus and mother if left untreated. The most\ncommon uses of non-steroidal anti-inflammatory drugs (NSAIDs) are the treatment of inflammation,\npain and pyrexia. However, after 20-30 weeks of gestation, using NSAIDs during pregnancy may\ncause oligohydramnios and premature ductus arteriosus closure, which could harm the developing\nfetus.\n\n\n\nThe purpose of this review article is to critically examine the clinical evidence that is\ncurrently available for oligohydramnios and premature ductus arteriosus closure linked to NSAIDs.\n\n\n\nOnline databases such as Medline/Pubmed/PMC, EBSCOhost, Scopus, Web of science,\nEmbase, Science Direct, Google Scholar, and reference lists were searched to identify articles which\ndealt with NSAIDs-associated oligohydramnios and premature closure of ductus arteriosus.\n\n\n\nNumerous regulatory agencies released warnings about oligohydramnios and premature closure\nof ductus arteriosus linked to NSAIDs. Furthermore, a number of case reports, case series, and\nsome observational studies have also been published about the possibility of oligohydramnios and\npremature closure of ductus arteriosus linked to NSAIDs use.\n\n\n\nWomen who are pregnant for 20 weeks or more should refrain from self-medicating\nwith NSAIDs without consulting a pharmacist or a physician. The use of NSAIDs during pregnancy\nshould carefully be considered due to potential risks to the mother and developing fetus, especially\nafter 20-30 weeks of gestation. To guarantee the best possible health for the expectant mother and the\nunborn child, healthcare professionals should weigh the benefits and risks and look into alternate\noptions. Pregnant women may opt for acetaminophen (paracetamol) to relieve pain and fever during\npregnancy. Pregnant women should seek medical attention if there is persisting pain for more than\nthree days.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855308697240409035903","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Pregnant women may experience low back pain and other pain symptoms, fever, and inflammatory conditions that may harm the fetus and mother if left untreated. The most common uses of non-steroidal anti-inflammatory drugs (NSAIDs) are the treatment of inflammation, pain and pyrexia. However, after 20-30 weeks of gestation, using NSAIDs during pregnancy may cause oligohydramnios and premature ductus arteriosus closure, which could harm the developing fetus. The purpose of this review article is to critically examine the clinical evidence that is currently available for oligohydramnios and premature ductus arteriosus closure linked to NSAIDs. Online databases such as Medline/Pubmed/PMC, EBSCOhost, Scopus, Web of science, Embase, Science Direct, Google Scholar, and reference lists were searched to identify articles which dealt with NSAIDs-associated oligohydramnios and premature closure of ductus arteriosus. Numerous regulatory agencies released warnings about oligohydramnios and premature closure of ductus arteriosus linked to NSAIDs. Furthermore, a number of case reports, case series, and some observational studies have also been published about the possibility of oligohydramnios and premature closure of ductus arteriosus linked to NSAIDs use. Women who are pregnant for 20 weeks or more should refrain from self-medicating with NSAIDs without consulting a pharmacist or a physician. The use of NSAIDs during pregnancy should carefully be considered due to potential risks to the mother and developing fetus, especially after 20-30 weeks of gestation. To guarantee the best possible health for the expectant mother and the unborn child, healthcare professionals should weigh the benefits and risks and look into alternate options. Pregnant women may opt for acetaminophen (paracetamol) to relieve pain and fever during pregnancy. Pregnant women should seek medical attention if there is persisting pain for more than three days.
与孕期使用非甾体抗炎药有关的少子畸形和宫内动脉导管早闭--临床证据综述
孕妇可能会出现腰痛和其他疼痛症状、发烧和炎症,如果不及时治疗,可能会对胎儿和母亲造成伤害。非甾体抗炎药(NSAIDs)最常见的用途是治疗炎症、疼痛和热病。然而,在妊娠 20-30 周后,在孕期使用非甾体抗炎药可能会导致少尿症和动脉导管早闭,这可能会对发育中的胎儿造成伤害。我们检索了 Medline/Pubmed/PMC、EBSCOhost、Scopus、Web of science、Embase、Science Direct、Google Scholar 等在线数据库和参考文献列表,以确定与非甾体抗炎药相关的少尿症和动脉导管过早闭合的文章。此外,一些病例报告、系列病例和一些观察性研究也已发表,说明使用非甾体抗炎药可能会导致少子畸形和动脉导管早闭。怀孕 20 周或更长时间的妇女应避免在未咨询药剂师或医生的情况下自行服用非甾体抗炎药。由于非甾体抗炎药对母亲和发育中的胎儿(尤其是妊娠 20-30 周后的胎儿)有潜在风险,因此在怀孕期间使用非甾体抗炎药应慎重考虑。为了保证孕妇和胎儿的最佳健康状况,医护人员应权衡其益处和风险,并考虑其他选择。孕妇可以选择对乙酰氨基酚(扑热息痛)来缓解孕期疼痛和发烧。如果疼痛持续超过三天,孕妇应及时就医。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信